Explore the complete record of transactions filed by Robins Chad M, 首席执行官. Director active across 1 company, notably Adaptive Biotechnologies Corp. Aggregated, 29 filings have been recorded. Breakdown: 0 buy · 17 sells. Total volume traded: €28.1m. Activity tracked since 15 June 2021. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Robins Chad M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
ROBINS CHAD M is Directeur Général and, at Adaptive Biotechnologies Corp (XNAS), is listed as CEO and Chairman. The record shows 23 filings in total, and across the sampled recent filings, all transactions are sales, for EUR 15272858 between 2021-06-17 and 2026-04-08.